Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending March 2009. The document serves as a notice of the Company's Annual General Meeting (AGM) scheduled for May 20, 2009, and confirms the submission of the 2008 Annual Report to the UK Listing Authority.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report is a procedural notice regarding corporate governance and document availability rather than a financial results announcement.
Material Changes
No material financial changes or comparative period data are disclosed in this filing.
Guidance, Outlook, and Risks
Management commentary, financial guidance, outlook, risks, contingencies, and unusual items are not addressed in this specific document. The filing directs investors to the 2008 Annual Report for detailed corporate information.
Important Facts for Investors
- The Annual General Meeting is scheduled for Wednesday, May 20, 2009, at 2:30 pm at the Queen Elizabeth II Conference Centre in London.
- The 2008 Annual Report and Notice of AGM have been submitted to the UK Listing Authority and are available for inspection at the Financial Services Authority in Canary Wharf.
- These documents are also accessible on the Company's website at www.gsk.com.
- This filing contains no financial performance data for the period ending March 2009.